Logo

BMS Collaborates with Voluntis to Co-Develop Digital Therapies to Treat Cancer Indications

Share this

BMS Collaborates with Voluntis to Co-Develop Digital Therapies to Treat Cancer Indications

Shots:

  • The collaboration will deploy Voluntis’ Theraxium Oncology- a platform for digital therapies in oncology and will evaluate potential solutions to support the management of patients symptoms & remote monitoring by HCPs
  • The focus of the collaboration is to develop digital therapies- providing patients access to a mobile app to support the treatment and track symptoms. The companies will evaluate how digital solutions enable patients to communicate with their HCPs- track symptoms and receive a personalized supportive care plan
  • The app will be developed to entrench evidence-based algorithms intended to provide patients with real-time recommendations for self-management of symptoms regarding therapy

Click here ­to­ read full press release/ article |

Ref: BMS | Image: BMS 


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions